- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01915654
Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients (CGRCard)
Impact de la Transfusion de Culots Globulaires de Moins de 14 Jours Sur la Morbi-mortalité Chez Des Patients en Chirurgie Cardiaque
The purpose of the transfusion of packed red blood cell is to overcome acute or chronic anemia cause tissue hypoxia. It increases hemoglobin concentration and consequently increase oxygen delivery to peripheral tissues. The perioperative period of major surgery is a field particularly favorable to the development of tissue hypoxia, which is associated with increased mortality and postoperative morbidity. Optimization of oxygen transport to tissues at the preoperative period is accompanied by a significant reduction of these major complications.
Clinical complications (infectious or otherwise) related to transfusion of caps Red Blood cells Caps (RBC)are well known. Many studies seem to evidence the potentially deleterious effect of transfusion, especially in patients with poor condition, related to storage time. Indeed, during storage, impaired blood-related storage is created. It is metabolic, biochemical and molecular levels. Many studies, carried out in particular in cardiac surgery where patients are suitable for transfusion RBC, have focused on the effect of transfusions on consumption and the transport of oxygen to demonstrate the impact of conservation lesions on their role in vivo. In particular, a single-center retrospective American study showed reduction of postoperative complications in patients who received RBC under 14 days.
However one of the confounding factors present is that all transfused RBCs are not leukoreduced (unlike the French transfusion policy). In addition, the greater part of the clinical studies are controversial. That is why we aim to assess, through a retrospective study of data, the impact of transfusion of red red blood cells within 14 days of post-operative morbidity and mortality, compared to the usual transfusion practice in cardiac surgery patients.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Besançon, France, Besançon
- Centre Hospitalier Universitaire de Besancon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients male or female over the age of 18 years
- Patients able to understand the benefits and risks of testing
- For the study population: patients who underwent cardiac surgery (all surgery combined) scheduled or emergency December 2008 to May 2009, having been transfused intraoperatively and until the seventh postoperative day .
- For the reference population: patients who have undergone elective or emergency cardiac surgery from December 2007 to May 2008 and from December 2009 to May 2010, having been transfused intraoperatively and until the seventh postoperative day.
Exclusion Criteria:
- Inability to understand the advantages and disadvantages of the study, psychiatric disorders judged by the investigator to be incompatible with the inclusion in the study.
- Patients who have expressed opposition to his participation in the study.
- For the study population: patients were transfused within seven days before the start of the observation period.
- For the study population: patients with transfusion of red blood cell more than 14 days
- For the reference population: patients were transfused within seven days before surgery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study population
The study involves patients operated in the cardiothoracic and cardio-vascular surgery department of Besançon University Hospital between December 2008 and May 2009 (study population) or between December 2007 and May 2008 and between December 2009 and May 2010 (reference population).
|
Population of patients undergoing cardiac surgery between December 2008 and May 2009, with pellets transfused RBCs stored for less than 14 days
|
Reference population
The study involves patients operated in the cardiothoracic and cardio-vascular surgery department of Besançon University Hospital between December 2008 and May 2009 (study population) or between December 2007 and May 2008 and between December 2009 and May 2010 (reference population).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
death / acute renal failure / operating / stroke / postoperative ischemia post infection
Time Frame: in-beyond the 48th hour of the transfusion
|
The primary endpoint was the occurrence of death and / or acute renal failure and / or operating and / or stroke and / or postoperative ischemia post infection, in-beyond the 48th hour of the transfusion.
|
in-beyond the 48th hour of the transfusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality / average length of stay in intensive care / resuscitation (> 48 hours) / the average length of stay in cardiac surgery
Time Frame: 30 days
|
The secondary endpoints were mortality at 30 days, the average length of stay in intensive care / resuscitation (> 48 hours) and (> 15 days).
|
30 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Guillaume Flicoteaux, CHRU De Besancon
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P/2013/194
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative; Dysfunction Following Cardiac Surgery
-
Tampere University HospitalTampere University of TechnologyCompletedPostoperative; Dysfunction Following Cardiac Surgery | Postoperative; Dysfunction Following Lung SurgeryFinland
-
Hull University Teaching Hospitals NHS TrustCompletedPostoperative; Dysfunction Following Cardiac SurgeryUnited Kingdom
-
University Health Network, TorontoToronto General HospitalRecruitingPostoperative; Dysfunction Following Cardiac SurgeryCanada
-
Luciana ChiavegatoCompletedPostoperative; Dysfunction Following Cardiac Surgery
-
Odense University HospitalCompletedPostoperative; Dysfunction Following Cardiac SurgeryDenmark
-
University of Sao PauloUnknownPostoperative; Dysfunction Following Cardiac SurgeryBrazil
-
Hamilton Health Sciences CorporationCompletedPostoperative; Dysfunction Following Cardiac SurgeryCanada
-
Hamilton Health Sciences CorporationCompletedPostoperative Dysfunction Following Cardiac SurgeryCanada
-
Xijing HospitalUnknownIntubation Complication | Complication of Ventilation Therapy | Postoperative; Dysfunction Following Cardiac Surgery
-
Aarhus University HospitalCompletedPostoperative; Dysfunction Following Cardiac Surgery
Clinical Trials on study population
-
Assistance Publique - Hôpitaux de ParisMerck Sharp & Dohme LLCRecruitingPulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)France
-
University Medical Centre LjubljanaRecruitingHelicobacter Pylori Infection | TransmissionSlovenia
-
Seoul National University HospitalCompletedSagging Eyelid Skin
-
Assistance Publique - Hôpitaux de ParisAgence Nationale de Recherche (ANR) National Research AgencyCompletedMental Disorder, ChildFrance
-
Washington University School of MedicineCompletedSingle Ventricle Fontan PalliationUnited States
-
Columbia UniversityAllerganCompletedBrittle NailsUnited States
-
Todos Medical, Ltd.Unknown
-
M.D. Anderson Cancer CenterActive, not recruitingVaccinationsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingPediatric CancerUnited States
-
Reyhan KaygusuzTerminatedHeart Diseases | Exercise Addiction | SensitivityTurkey